Safety Study of ORG 34517 for Major Depression With Psychotic Features

Summary

Patients suffering from Major Depressive Disorder with Psychotic features who have received no changes in their medications in the previous two weeks will receive "usual" treatment of antidepressants, antipsychotics and/or mood stabilizers and adjunct therapy using ORG34517. The patient will be hospitalized for up to two weeks to monitor their medications and progress and will return to the site for periodic assessments.

Timeline

Start

2004-09

Primary completion

2005-11

Completion

2005-11

Drugs

Indications